Search results
Added:
4 years ago
Prof Jean-Claude Tardif (University of Montreal & Montreal Heart Institute, Montreal, QC, CA) discusses the results of the COLCOT Trial.
Questions:
1. What is colchicine and what is the COLCOT study?
2. Could you describe the study design, patient population and endpoints?
3. What were your findings?
4. Does this study fully validate the anti-inflammation hypothesis and transcend into practice?…
View more
Added:
2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Pim van der Harst and Dr Marie-Sophie de Koning (University Medical Center Groningen, NL) discuss the data from the GIPS-IV trial which investigates the safety and efficacy of the hydrogen sulfide (H2S) donor sodium thiosulfate (STS) in patients presenting with ST-segment elevation myocardial infarction (STEMI) …
View more
Added:
2 years ago
In this short interview from our coverage of ACC.22 late-breaking trials, Dr Manesh Patel (Duke Heart Center, US) discusses the multicentre, randomised, double-blind PACIFIC-AF trial (Bayer)(NCT04218266).
The trial sought to determine the efficacy of the oral FXIa inhibitor asundexian and evaluate the safety of the drug, compared to the non-vitamin K oral anticoagulant (NOAC) apixaban, in…
View more
Added:
2 years ago
In this interview, Dr Susheel Kodali (Columbia University Medical Center, New York, US) discusses the 30-day results of the TRISCEND trial. He details the key findings of the study so far, and the next steps to be taken.Thismulti-centre, prospective, single-arm study evaluates the safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
Questions:
1.What is the TRISCEND…
View more
Added:
2 years ago
In this late-breaking interview filmed at EHRA 2022, Dr José Merino(Hospital Universitario La Paz, Madrid, Spain) discusses the findings of the POWER-FAST III trial, a study that aimed to compare atrial fibrillation ablation strategies of conventional radiofrequency ablation and high power radiofrequency ablation. Results suggest that PVA was achieved in both cohorts, with no significant…
View more
Added:
1 year ago
In this interview, recorded at TCT 2022 in Boston (US), just afterthe results of PREDICT-LAA were presented,Prof Ole De Backer (Rigshospitalet, Copenhagen University Hospital, DK), the lead investigator of the trial,explains the core objectives of PREDICT-LAA and the key results that him and his investigators observed during this randomisedtrial.Watch the interview to discover PREDICT-LAA's…
View more
Added:
3 years ago
Prof Michiel Rienstra (University Medical Center Groningen, Groningen, NL) and Dr Gijs van Woerden (University Medical Center Groningen, Groningen, NL)discuss the results of the VIP-HF study.
The VIP-HF study examined whether an implantable loop recorder (ILR) could be used in patients with HFpEF to evaluate the incidence of sustained ventricular tachyarrhythmias.
Questions:
1.What prompted…
View more
Added:
2 years ago
Dr Luis Ortega-Paz (Hospital Clinic de Barcelona, Barcelona, ES) discusses the 2-year results from the MAGSTEMI Trial. Thestudy comparedthe in-stent/scaffold vasomotionbetweenMgBRS and permanent metallic sirolimus-eluting stent (SES) at 12-month follow-up in ST-segment–elevation myocardial infarction patients.
Questions:
1. What was the rationale for the MAGSTEMI Trial?
2. Please remind us…
View more
Added:
2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Brian Bergmark (Brigham and Women's Hospital, Harvard Medical School, US) discusses the data from the TRANSLATE-TIMI 70 study; a phase 2b, randomised trial of vupanorsen (an antisense oligonucleotide)(NCT04516291).
The primary objective was to evaluate the effect of vupanorsen on non-high-density lipoprotein (non-HDL…
View more
Added:
4 years ago
Prof Kausik K Ray (Imperial College London, UK) discusses results of theresutls of the Phase 3 ORION-11 trial - Impact of inclisiran on LDL-C over 18 months in patients with ASCVD or risk-equivalent.
Filmed on site at ESC 2019 by Radcliffe Cardiology.
View more
